FOLLICULAR LYMPHOMAS

Clinical trials for FOLLICULAR LYMPHOMAS explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR LYMPHOMAS trials appear

Sign up with your email to follow new studies for FOLLICULAR LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug cocktail aims to boost lymphoma remission

Disease control Not yet recruiting

This study compares two treatment combinations for people newly diagnosed with follicular lymphoma, a slow-growing blood cancer. One group gets the standard R2 regimen (rituximab and lenalidomide), while the other adds zanubrutinib (ZR2). The goal is to see if the three-drug comb…

Matched conditions: FOLLICULAR LYMPHOMAS

Phase: PHASE2 • Sponsor: KeshuZhou • Aim: Disease control

Last updated May 10, 2026 12:03 UTC

FOLLICULAR LYMPHOMAS

Get alerted when new FOLLICULAR LYMPHOMAS trials appear

New drug cocktail aims to boost lymphoma remission